Global Health IPO 2022 dates, price band, listing details

What the Global Health IPO was about

Global Health Ltd, the hospital operator behind the Medanta brand, came to the market with an initial public offering (IPO) in November 2022. The issue was structured as a book-built offer with a price band of ₹319 to ₹336 per share. The IPO combined a fresh issue and an offer for sale (OFS), with the total issue size disclosed at ₹2,205.57 crore. At the upper end of the band, the total fundraise was projected at about ₹2,206 crore.

For investors tracking healthcare listings, the offer drew attention because it included participation by institutional investors through an anchor book, and because the issue saw a sharp difference in demand across investor categories. The stock ultimately listed on both NSE and BSE.

Key IPO dates: open, close, allotment and listing

The IPO opened for subscription on Thursday, November 3, 2022 and closed on Monday, November 7, 2022. The listing date was Wednesday, November 16, 2022 on NSE and BSE.

The timeline shared for post-issue activities included finalisation of the basis of allotment around November 11, 2022. In the provided details, the allotment date is also mentioned as November 10, 2022, while multiple schedules show basis finalisation on November 11, 2022. Refund initiation for unallotted applicants began on November 14, 2022, and shares were credited to demat accounts on November 15, 2022.

Price band, lot size and minimum investment

Global Health Ltd fixed the IPO price band at ₹319 to ₹336 per equity share (face value ₹2 each). The lot size was set at 44 shares and bids were accepted in multiples of 44.

At the upper end of the price band (₹336), the minimum retail application amount worked out to ₹14,784 for 1 lot (44 shares). Retail investors were allowed to apply for up to 13 lots, or 572 shares, which worked out to ₹1,92,192 at ₹336 per share.

Issue structure: fresh issue and OFS

The IPO consisted of a fresh issue of equity shares aggregating to ₹500 crore and an offer for sale of up to 5.08 crore equity shares. Another disclosed split described the overall ₹2,205 crore-plus IPO as ₹500 crore of fresh issue and about ₹1,706 crore of OFS.

Within the OFS, selling shareholders included Anant Investments (associated with Carlyle Group) and Sunil Sachdeva and Suman Sachdeva, who divested portions of their holdings. The offer was positioned as a combination of capital raised for the company through the fresh issue and liquidity for existing shareholders through the OFS.

Anchor book: ₹662 crore raised before the opening

Ahead of the IPO, Global Health raised ₹662 crore from anchor investors. The disclosed allocation to anchor investors was 1.97 crore equity shares at ₹336 each.

The list of anchor investors mentioned in the provided information included domestic mutual funds and insurers such as Axis Mutual Fund, HDFC Mutual Fund, Aditya Birla Sun Life Mutual Fund, SBI Mutual Fund, ICICI Prudential Mutual Fund, Kotak Mutual Fund, Max Life Insurance, and SBI Life Insurance. The anchor participation is typically watched because it signals institutional appetite ahead of the main subscription window.

Subscription numbers: strong QIB demand, weaker retail

As of November 7, 2022 (issue close), the IPO subscription was reported at about 9.58 times overall. The category-wise demand showed a wide gap between institutional and retail participation.

Qualified institutional buyers (QIBs) subscribed heavily, while retail subscription remained below 1 time in the disclosed data. Non-institutional investors (NIIs) subscribed at a moderate multiple.

IPO schedule and subscription snapshot (table)

Grey market premium (GMP) data mentioned

The provided information cited a tentative grey market premium (GMP) of ₹20 for the IPO. Another data point mentioned that the grey market premium was around ₹25 per share, according to trackers referenced in the source text.

GMP is an unofficial indicator and not a regulated market metric. Still, it is often monitored by retail applicants during the bidding period as a sentiment gauge.

Listing outcome: price, gain and current market reference

Global Health Ltd listed on November 16, 2022 with a disclosed listing price of ₹401. The listing gain was reported at 19.35% compared with the IPO price.

The provided market snapshot also included a later reference point: as on 24-Jun-2026 16:00:00 IST, the stock’s CMP was ₹1,350.7 and the open was ₹1,303.00. The same data block reported a 52-week low of ₹956.00 (dated 30-Mar-2026), along with an upper band of ₹1,582.00 and a lower band of ₹1,054.80, with a price band percentage of 20% and tick size of ₹0.10.

How to check Global Health IPO allotment status

Applicants were directed to check allotment status through KFin Technologies. The process outlined was to visit https://kosmos.kfintech.com/ipostatus, select the relevant IPO, enter PAN or application number, and view the status.

This method is commonly used for IPO registrar checks, and the data shown reflects the finalised allotment once updated by the registrar.

Why the details mattered to investors

For IPO applicants, the Global Health issue combined several elements that influence subscription and post-listing attention: a relatively tight subscription window, anchor participation of ₹662 crore, and sharply higher demand from QIBs than from retail investors. The disclosed subscription pattern highlighted that institutional demand was the primary driver of overall oversubscription.

From a trading perspective, the key takeaway was the listing at ₹401 and the reported 19.35% listing gain, which provided an immediate benchmark against the ₹336 issue price. Separately, later market data points (CMP, open, 52-week low, and trading bands) provide context on how the stock traded well after the IPO period.

Conclusion

Global Health Ltd’s IPO ran from Nov 3 to Nov 7, 2022, with allotment finalisation around Nov 11 and listing on Nov 16, 2022 on NSE and BSE. The issue was priced at ₹319 to ₹336, offered in lots of 44 shares, and saw overall subscription of about 9.58 times led by QIB demand. The next formal checkpoints for applicants during the issue were registrar updates for allotment status, refunds from Nov 14, and demat credit on Nov 15, ahead of the listing on Nov 16.